Video Analysis for Laszlo Lorand - Factor XIII - Keynote address
May 25, 2014
600 x 360
5 / 5 (0 ratings)
5 / 5
EST. TOTAL REVENUE
$0 - $0
EST. MONTHLY REVENUE
$0 - $0
EST. YEARLY REVENUE
AVG. DAILY VIEWS
AVG. DAILY LIKES
AVG. DAILY DISLIKES
* We try our best to gather the video's growth rate. This is an estimate for a cumulative growth of views.
Laszlo Lorand - Factor XIII - Keynote address
László Lóránd - Northwestern University, Feinberg Medical School, Chicago, IL. 60611
European Thrombosis Research Organization
International Factor XIII Workshop
Debrecen, Hungary, 2012 Read more »
Laszlo Lorand - Factor XIII - Keynote address - YouTube
Translational research par excellence - From molecules to diseases of clot stabilization László Lóránd - Northwestern University, Feinberg Medical ...
Laszlo Lorand - Wikipedia, the free encyclopedia
Laszlo Lorand; Born March 23, 1923 (age 92) Győr ... He was a co-discoverer of the substance that later became known as factor XIII. He is a member of the National ...
XIII DISEASED - YouTube
This feature is not available right now. Please try again later. Published on Mar 3, 2015. Category . Music; License . Standard YouTube License
Learn and talk about Factor XIII deficiency ...
... all focused on Factor XIII deficiency , and makes it easy to learn, explore, and join the Digparty and talk to ... Laszlo Lorand - Factor XIII - Keynote address.
Reactivity of the N-terminal Region of Fibronectin Protein to Transglutaminase 2 and Factor XIIIA *
Keywords: Collagen, Extracellular Matrix, Fibronectin, Mass Spectrometry (MS), Protein Cross-linking, Factor XIII, Thermolysin, Transglutaminase 2 Trypsin and thermolysin were used, respectively, at concentrations of 0.1–100 μg/ml and 0.1–30 μg/ml ...
Global Advances in Health and Medicine
Global Advances in Health and Medicine (GAHMJ) reflects a systems approach to medicine, focusing on the global convergences in health and medicine, systems-oriented approaches to healthcare, and high-quality case reports.
Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer Drugs
On the basis of the assay she received high-dose adriamycin (70 mg per square meter) and high-dose methotrexate (1 g per square meter) with citrovorum-factor rescue ... College of Medicine (address reprint requests to Dr. Salmon at the Section of ...
- Show More